CATUG Biotechnology

CATUG Biotechnology is an international CRDMO/CDMO specializing in nucleic acid therapeutics—including plasmid DNA, mRNA, siRNA/circRNA/saRNA—and advanced lipid nanoparticle delivery systems. The company provides end-to-end solutions from research/discovery through GMP manufacturing and commercialization. It enables the development of gene/cell therapies and RNA medicines by offering custom synthesis/formulation services with state-of-the-art analytical QC capabilities. Its expertise includes high-purity mRNAs/LNPs for vaccines or immunotherapies and support for complex genetic engineering such as iPSC-derived immune cells or CAR-modified cells through partnerships. The company does not appear to have its own proprietary clinical pipeline but instead powers the pipelines of biotech/pharma clients globally.